Electrocardiographic characterization of ramucirumab on the corrected qt interval in a phase ii study of patients with advanced solid tumors

Anthony J. Olszanski, David C. Smith, Luis H. Camacho, John Thompson, Suresh S. Ramalingam, R. Donald Harvey, Luis Campos, David Ferry, Shande Tang, Ling Gao, Howard Safran

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Electrocardiographic characterization of ramucirumab on the corrected qt interval in a phase ii study of patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science